Stay updated with breaking news from Falk Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN MATEO, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional
In a population-based, sibling-controlled cohort study Jiangwei Sun and colleagues explore the long-term risk of arrhythmias in patients with inflammatory bowel disease.
Freedom House Ambulance Service was America’s first ambulance service staffed by Black citizens trained to save lives.
Jiangwei Sun and colleagues investigate the long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa in a Swedish cohort.
Mirikizumab targets a subunit of interleukin 23, which has shown promise in other conditions.